Log in or Sign up for Free to view tailored content for your specialty!
PTSD News
Jazz Pharmaceuticals PTSD treatment fails to meet endpoints in phase 2 trial
Jazz Pharmaceuticals’ experimental PTSD treatment failed to meet the primary endpoint in a phase 2 trial, the company announced in a press release.
One-quarter of U.S. adults want to improve their mental health in 2024
Focusing on mental health is one of the most popular New Year’s resolutions U.S. adults are making for 2024, according to a press release from the American Psychiatric Association.
Log in or Sign up for Free to view tailored content for your specialty!
Public benefit corporation submits NDA to FDA for MDMA-assisted therapy to treat PTSD
A public benefit corporation that develops psychedelic therapies has submitted a new drug application to the FDA this week to use MDMA combined with psychotherapy to treat PTSD, according to a press release.
Silo Pharma, Medspray make deal for nasal spray delivery of PTSD, anxiety drug
A new licensing agreement between Silo Pharma and Medspray Pharma BV allows SPC-15, Silo’s therapeutic for PTSD, anxiety and more, to be delivered via Medspray’s soft mist nasal spray technology, according to a Silo press release.
Families of those with Dravet require better access to physical, mental health care
ORLANDO — Caregivers of patients in the U.K. with Dravet syndrome would benefit from better communication, access to health care and increased psychosocial interventions, per a poster at the American Epilepsy Society annual meeting.
'A Promethean moment': Psychedelics could be prescribed in the next few years
With potential FDA approvals on the horizon, the controversy surrounding psychedelics in clinical practice may soon reach a tipping point, according to experts.
FDA warns against use of products with tianeptine
The FDA has issued a warning against the purchase or use of products that contain tianeptine, which has been illegally sold with claims to improve brain function and treat anxiety, depression, pain, opioid use disorder and other conditions.
Psychedelics have ‘potential to be transformative’ in saving health care system millions
Long-term treatment with psychedelics holds the potential to transform the health care industry through millions in savings, according to an expert at a congressional briefing hosted by Johns Hopkins University.
Yoga intervention significantly reduced stigma of epilepsy, improved quality of life
Yoga therapy significantly reduced the felt stigma of epilepsy along with improving anxiety and quality of life at 6 months compared to sham, according to research presented in Neurology.
Poll: Americans feel better after small acts of kindness
Small acts of kindness make most U.S. adults feel better, whether they are receiving them or giving them, according to the results of a recent poll by the American Psychiatric Association.
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read